Pentasa® is indicated for the induction and maintenance of remission in mild to moderate Ulcerative Colitis1-7
PRODUCT INFORMATION
Pentasa is unique, as it’s the only time-dependent release 5-ASA formulation which releases 5-ASA regardless of pH1-5,8-11
Time-dependent release ensures consistent delivery of mesalazine throughout the entire colon, with 80% delivered to the large colon, ensuring efficacy in UC, including left-sided disease1-5,12
Optimised PENTASA treatment:
Achieves remission within 2 weeks and maintains remission for 12 months13,14*
Has proven efficacy in moderate and left-sided UC patients13,15,16
Achieves and maintains high rates of mucosal healing13,15
*Included once-daily PENTASA enema for the first 4 weeks
Job Code: UK-PA-2400044 - Date of preparation: November 2024
Our use of cookies
We use cookies (including third party cookies) to collect data while you use this website in order to make it work, keep it secure and comply with regulations. We’d also like your consent to use cookies so we can provide you with tailored content and advertising and analyse how you and other people use the website.
Select “On” to consent to our use of these cookies and continue to the website, or select “Off” to control which types of cookies we use. You can read more about cookies in our Privacy Policy.
Necessary cookies
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
Analytics cookies
We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in away that does not directly identify anyone. For more information on how these cookies work, please see our Privacy Policy.